Skip to main navigation Skip to search Skip to main content

Inactivation of the mouse huntington's disease gene homolog Hdh

  • Mabel P. Duyao
  • , Anna B. Auerbach
  • , Angela Ryan
  • , Francesca Persichetti
  • , Glenn T. Barnes
  • , Sandra M. McNeil
  • , Pei Ge
  • , Jean Paul Vonsattel
  • , James F. Gusella
  • , Alexandra L. Joyner
  • , Marcy E. MacDonald

Research output: Contribution to journalArticlepeer-review

Abstract

Huntington's disease (HD) is a dominant neurodegenerative disorder caused by expansion of a CAG repeat in the gene encoding huntingtin, a protein of unknown function. To distinguish between "loss of function" and "gain of function" models of HD, the murine HD homolog Hdh was inactivated by gene targeting. Mice heterozygous for Hdh inactivation were phenotypically normal, whereas homozygosity resulted in embryonic death. Homozygotes displayed abnormal gastrulation at embryonic day 7.5 and were resorbing by day 8.5. Thus, huntingtin is critical early in embryonic development, before the emergence of the nervous system. That Hdh inactivation does not mimic adult HD neuropathology suggests that the human disease involves a gain of function.

Original languageEnglish
Pages (from-to)407-410
Number of pages4
JournalScience
Volume269
Issue number5222
DOIs
Publication statusPublished - 1995
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Inactivation of the mouse huntington's disease gene homolog Hdh'. Together they form a unique fingerprint.

Cite this